VisionHealth and Boehringer Ingelheim: Digital therapy support for asthma and COPD VisionHealth and Boehringer Ingelheim cooperate on distribution of inhalation platform Kata® The Kata® app guides and records correct inhalation and therapy delivery Precise use of inhalation devices is vital for successful therapy   Munich, July 12th, 2022 – VisionHealth

VisionHealth’s Kata® Clinical to be included into Alcedis service platform for clinical studies Kata® Clinical app supports clinical trials in the field of chronic lung diseases and can be customized to each trial’s individual requirements Based on artificial intelligence (AI), Kata® Clinical can improve both study outcomes and participants’ experience

VisionHealth receives EU Medical Device Regulation certification VisionHealth is among the first app manufacturers to receive EU Medical Device Regulations (MDR) certification MDR certification prerequisite to enhance, further develop and release future Kata® versions Next Kata® app version will be a CE marked class IIa medical device (MDR)   Munich